© 2026 MergersCorp M&A International.
is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://dev.cherrycoding.com/mergerscorp/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.MergersCorp M&A International franchising program is not offered to individuals or entities located in the United States
The franchising program is offered by MergersUK Limited a UK Company with registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom
多家持有 GDP 和麻醉品许可的德国药品分销公司分销医用大麻。 这些 “交钥匙 “平台已完全符合德国的基础设施要求,可立即进入德国市场。
德国一家获得全面许可的医药分销实体,专为医用大麻行业而建。 公司以精简、轻资产的模式运营,在物流、合规性和质量保证方面利用成熟的第三方合作伙伴,确保高效运营,为快速进入市场奠定可扩展的基础。
列表详情
© 2025 MergersCorp M&A International is a global brand operating through a number of professional firms and constituent entities (“Members”) located throughout the world to provide Investment Banking, Corporate Finance, and Advisory Services and other client-related professional services. The Member Firms (“Members”) are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit our Disclaimer: https://mergerscorp.com/disclaimer. MergersCorp M&A International's franchising program is not offered to individuals or entities located in the United States.
The franchising program is offered by MergersUK Limited, a UK Company with its registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
MergersCorp M&A International provides strategic business advisory services, including preparing companies for growth and capital access. Through partnerships with licensed investment bankers, clients can access tailored capital-raising solutions.
U.S. Investment Banking Securities transactions are exclusively conducted by Spektrum Capital Advisors LLC, a Registered Representative of, and Securities Products offered through, BA Securities, LLC, a FINRA-registered broker-dealer. Check the background of investment professionals associated with this site on Broker Check.
This website is operated by MergersUS Inc a US Corporation with registered office at





描述
多家持有 GDP 和麻醉品许可的德国药品分销公司分销医用大麻。 这些 “交钥匙 “平台已完全符合德国的基础设施要求,可立即进入德国市场。
德国一家获得全面许可的医药分销实体,专为医用大麻行业而建。 公司以精简、轻资产的模式运营,在物流、合规性和质量保证方面利用成熟的第三方合作伙伴,确保高效运营,为快速进入市场奠定可扩展的基础。
列表详情
Basic Details
Target Price:
$ 0
Gross Revenue
TBD
EBITDA
TBD
Business ID:
L#20261068
Country
德国
详情
Published on 30 5 月, 2026 在 7:29 下午. 更新 30 5 月, 2026 在 7:29 下午